LENNOX GASTAUT SYNDROME
Clinical trials for LENNOX GASTAUT SYNDROME explained in plain language.
Never miss a new study
Get alerted when new LENNOX GASTAUT SYNDROME trials appear
Sign up with your email to follow new studies for LENNOX GASTAUT SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Safety check: monitoring liver health in patients taking seizure medication
Disease control OngoingThis study aims to monitor for potential long-term liver effects in people taking Epidiolex (cannabidiol) for severe seizure disorders. Researchers will follow 154 participants who are either already taking Epidiolex or starting it for FDA-approved conditions. The main goal is to…
Matched conditions: LENNOX GASTAUT SYNDROME
Phase: PHASE4 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Brain implant tested to tame severe seizures
Disease control OngoingThis study is testing the safety and early effectiveness of an implanted brain stimulation device for people with a severe form of epilepsy called Lennox-Gastaut Syndrome (LGS). The device, called the RNS System, is designed to detect and respond to abnormal brain activity to hel…
Matched conditions: LENNOX GASTAUT SYNDROME
Phase: PHASE2 • Sponsor: NeuroPace • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Special program keeps seizure medication available for patients
Disease control NO_LONGER_AVAILABLEThis program provided continued access to perampanel medication for people with epilepsy who had previously participated in related studies. It allowed patients to keep receiving their seizure medication until it became commercially available in their country. The program was des…
Matched conditions: LENNOX GASTAUT SYNDROME
Sponsor: Eisai Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC